Citadel Advisors’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $533K | Sell |
9,367
-16,528
| -64% | -$941K | ﹤0.01% | 3995 |
|
|
2025
Q1 | $1.45M | Buy |
25,895
+15,892
| +159% | +$891K | ﹤0.01% | 2889 |
|
|
2024
Q4 | $615K | Sell |
10,003
-6,918
| -41% | -$425K | ﹤0.01% | 3780 |
|
|
2024
Q3 | $1.13M | Sell |
16,921
-3,849
| -19% | -$258K | ﹤0.01% | 3007 |
|
|
2024
Q2 | $1.39M | Sell |
20,770
-18,448
| -47% | -$1.23M | ﹤0.01% | 2755 |
|
|
2024
Q1 | $2.79M | Buy |
39,218
+32,087
| +450% | +$2.28M | ﹤0.01% | 2210 |
|
|
2023
Q4 | $601K | Buy |
7,131
+2,522
| +55% | +$212K | ﹤0.01% | 3544 |
|
|
2023
Q3 | $396K | Sell |
4,609
-4,472
| -49% | -$385K | ﹤0.01% | 4005 |
|
|
2023
Q2 | $846K | Sell |
9,081
-323
| -3% | -$30.1K | ﹤0.01% | 3151 |
|
|
2023
Q1 | $891K | Buy |
9,404
+6,008
| +177% | +$569K | ﹤0.01% | 3293 |
|
|
2022
Q4 | $341K | Buy |
3,396
+883
| +35% | +$88.8K | ﹤0.01% | 4215 |
|
|
2022
Q3 | $214K | Buy |
+2,513
| New | +$214K | ﹤0.01% | 4817 |
|
|
2022
Q2 | – | Sell |
-4,451
| Closed | -$400K | – | 6947 |
|
|
2022
Q1 | $400K | Buy |
4,451
+2,128
| +92% | +$191K | ﹤0.01% | 4662 |
|
|
2021
Q4 | $233K | Buy |
+2,323
| New | +$233K | ﹤0.01% | 5355 |
|
|
2020
Q4 | – | Sell |
-2,833
| Closed | -$227K | – | 5608 |
|
|
2020
Q3 | $227K | Sell |
2,833
-432
| -13% | -$34.6K | ﹤0.01% | 4024 |
|
|
2020
Q2 | $290K | Sell |
3,265
-1,383
| -30% | -$123K | ﹤0.01% | 3835 |
|
|
2020
Q1 | $437K | Buy |
4,648
+2,530
| +119% | +$238K | ﹤0.01% | 3507 |
|
|
2019
Q4 | $229K | Sell |
2,118
-586
| -22% | -$63.4K | ﹤0.01% | 4056 |
|
|
2019
Q3 | $259K | Buy |
+2,704
| New | +$259K | ﹤0.01% | 3958 |
|
|
2018
Q4 | – | Sell |
-2,411
| Closed | -$227K | – | 4971 |
|
|
2018
Q3 | $227K | Buy |
+2,411
| New | +$227K | ﹤0.01% | 3666 |
|